Swiss cirrhosis study for liver patients and controls
Part of Digestive system clinical trials.
This study compares patients with advanced liver scarring (cirrhosis) to healthy controls to learn more about the condition. It may help researchers better understand and manage liver disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have long-term liver disease and confirmed cirrhosis (advanced liver scarring).
- Or you must be a healthy individual without any signs of cirrhosis.
- You must be 18 years or older.
- You must not have liver cancer (hepatocellular carcinoma or cholangiocellular carcinoma).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests remote monitoring for people with liver cirrhosis. Instead of always coming to the clinic, you may use tools at home to track your health, which could make managing your condition easier.
This study looks at people over 18 who have advanced, long-term liver scarring. It uses specialized measurements of liver stiffness and pressure to confirm eligibility and may help doctors better understand this condition.
This study looks at the bacteria in the gut of people with liver cirrhosis to better understand how they relate to the disease. By joining, you help researchers learn more about cirrhosis, which may lead to better care in the future.
This study follows people with cirrhosis to see how best to detect liver cancer early. If you qualify, you may receive regular monitoring that could help find liver cancer sooner, when treatment is more likely to work.
This study looks at how your body uses protein in your muscles when you have cirrhosis (a scarred liver). It uses a special “tracer” method (a substance that can be tracked) and may help researchers better understand muscle loss in people with milder cirrhosis.
This study looks at how gut bacteria change in people with liver cirrhosis and whether these changes relate to how the disease progresses. It may help find new ways to monitor or treat cirrhosis.
Hear when a new Liver Cirrhosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.